Oklahoma 2022 Regular Session

Oklahoma House Bill HB4416 Latest Draft

Bill / Introduced Version Filed 01/21/2022

                             
 
Req. No. 9910 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 58th Legislature (2022) 
 
HOUSE BILL 4416 	By: Lowe (Dick) 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to medical marijuana; amend ing 63 
O.S. 2021, Section 427.17, which relates to the 
Oklahoma Medical Marijuana and Pat ient Protection 
Act; directing licensed medical marijuana growers to 
annually submit certain information to the Oklahoma 
Medical Marijuana Authority; and providing an 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPL E OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 427.17, is 
amended to read as follows: 
Section 427.17 A.  There is hereby created a medical marijuana 
testing laboratory li cense as a category of the medical marijuana 
business license.  The Oklahoma Medical Marijuana Authority is 
hereby enabled to monitor, inspec t and audit a licensed testing 
laboratory under the Oklahoma Medical Marijuana and Patient 
Protection Act. 
B.  The Authority is hereby authorized to contract with a 
private laboratory for the purpose of conducting compliance te sting 
of medical marijuana t esting laboratories licensed in this state .    
 
Req. No. 9910 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Any such laboratory under contract for compliance testing shall be 
prohibited from conducting any other commercial medical marijuana 
testing in this state.  The laboratory the Authori ty contracts with 
for compliance testing shall not employ, or be owned by, the 
following: 
1.  Any individual that has a direct or indirect inter est in a 
licensed medical marijuana business; or 
2.  Any individual or his or her spouse, parent, child, spouse 
of a child, sibling or spo use of a sibling that has an application 
for a medical marijuana business license pending before the 
Department or is a member of the board of directors of a medical 
marijuana business, o r is an individual financially interested i n 
any licensee or medical marijuana business located within this 
state. 
C.  The Authority shall develop acceptable testin g practices 
including, but not limited to, testing, standards, quality control 
analysis, equipment certification and calibration, and c hemical 
identification and substances used. 
D.  A person who is a direct beneficial owne r of a medical 
marijuana dispensary, medical marijuana c ommercial grower or medical 
marijuana processor shall not be an owner of a laboratory. 
E.  A laboratory and a l aboratory applicant sha ll comply with 
all applicable local ordinances including , but not limited to, 
zoning, occupancy, licensing and building co des.   
 
Req. No. 9910 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
F.  A separate license shall be required for each specific 
laboratory. 
G.  A medical marijuana testing lab oratory license may b e issued 
to a person who performs testin g on medical marijuana and medical 
marijuana products for medical marijuana business es, medical 
marijuana research facilities, medical marijuana educatio n 
facilities, and testin g on marijuana and marijuana products g rown or 
produced by a patient or caregiver on behalf of a patient, upon 
verification of registration .  A medical marijuana t esting 
laboratory may also conduct research related to the developmen t and 
improvement of its testing practices and procedures. No state-
approved medical marijuana testing facility shall operate unless a 
medical laboratory director is on site during opera tional hours. 
H.  Laboratory applicants and licensees shall comply with the 
application requirements of this se ction and shall submit such other 
information as required for a medical marijuana business applicant, 
in addition to any information the Authorit y may request for initial 
approval and periodic evaluations during th e approval period. 
I.  A medical marijuana testing laboratory may accept samples of 
medical marijuana, medical marijuana concentrate or medical 
marijuana product from a medical marijuana business, medical 
marijuana research facility or medical marijuana ed ucation facility 
for testing purposes only, which purposes may include the provision 
of testing services for samples submitted by a medical marijuana   
 
Req. No. 9910 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
business for product development .  The Department may require a 
medical marijuana business to submit a sam ple of medical marijuana, 
medical marijuana concentrate or medical marijuana product to a 
medical marijuana testing or quality assurance laboratory upon 
demand. 
J.  A medical marijuana te sting laboratory may accept samples of 
medical marijuana, medical mar ijuana concentrate or medical 
marijuana product from an individual person for testing only under 
the following conditions: 
1.  The individual person is a patient or caregiver pursuant t o 
the Oklahoma Medical Marijuana and Patient Protection Act or is a 
participant in an approved clinical or observ ational study conducted 
by a research facility; and 
2.  The medical marijuana testing laboratory shall require the 
patient or caregiver to produc e a valid patient license and current 
and valid photo identification. 
K.  A medical marijuana testing laborator y may transfer samples 
to another medical marijuana testing laboratory for testing .  All 
laboratory reports provided to or by a medical marijuana business or 
to a patient or caregiver shall identify the medical mar ijuana 
testing laboratory that actually co nducted the test. 
L.  A medical marijuana testing laboratory may utilize a 
licensed medical marijuana transporter to transport samples of 
medical marijuana, medical marijuana concentrate and medical   
 
Req. No. 9910 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
marijuana product for testing, in accordance wit h the Oklahoma 
Medical Marijuana and Patient Protection Act and the rules adopted 
pursuant thereto, between the originating medical marijuana business 
requesting testing services and the destination laboratory 
performing testing services. 
M.  The medical marijuana testing laboratory shall establish 
policies to prevent the existence of or appearance of undue 
commercial, financial or other influences that may diminish the 
competency, impartiality and integrity of the testing p rocesses or 
results of the laboratory, or that may diminish public confidence in 
the competency, impartiality and integrity of the testing processes 
or results of the laboratory .  At a minimum, employees, owners or 
agents of a medical marijuana testing lab oratory who participate in 
any aspect of the analysis and results of a sample are prohibited 
from improperly influencing the testing process, improperly 
manipulating data or improperly be nefiting from any ongoing 
financial, employment, personal or business relationship with the 
medical marijuana business that provided the sample.  A medical 
marijuana testing laboratory shall not test samples for any medical 
marijuana business in which an o wner, employee or agent of the 
medical marijuana testing laboratory h as any form of ownership or 
financial interest in the medical marijuana business.   
 
Req. No. 9910 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
N.  The Department, pursuant to rules promulgated by the State 
Commissioner of Health, shall develop stan dards, policies and 
procedures as necessary for: 
1.  The cleanliness and orderliness of a laboratory premises a nd 
the location of the laboratory in a secure location, and inspection, 
cleaning and maintenance of any equipment or utensils used for the 
analysis of test samples; 
2.  Testing procedures, testing standards for can nabinoid and 
terpenoid potency and safe le vels of contaminants, and remediation 
procedures; 
3.  Controlled access areas for storage of medical marijuana and 
medical marijuana product test samples, waste and reference 
standards; 
4.  Records to be retained a nd computer systems to be utilized 
by the laboratory; 
5.  The possession, storage and use by the laboratory of 
reagents, solutions and reference standards; 
6.  A certificate of analysis ( COA) for each lot of reference 
standard; 
7.  The transport and dispos al of unused marijuana, marijuana 
products and waste; 
8.  The mandatory use by a laboratory of an inventory tracking 
system to ensure all harvest and production batches or samples 
containing medical marijuana, medical marijuana concentrate or   
 
Req. No. 9910 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
medical marijuana products are identified and tracked f rom the point 
they are transferred from a medical marijuana business, a patient or 
a caregiver through the point of transfer, destruction or disp osal.  
The inventory tracking system reporting shall include the resu lts of 
any tests that are conducted on med ical marijuana, medical marijuana 
concentrate or medical marijuana product; 
9.  Standards of performance; 
10.  The employment of laboratory perso nnel; 
11.  A written standard operating procedure manual to be 
maintained and updated by the laboratory; 
12.  The successful participation in a Department -approved 
proficiency testing program for each testing category listed in this 
section, in order to ob tain and maintain certification; 
13.  The establishment of and adhere nce to a quality assurance 
and quality control program to ensure sufficient monitoring of 
laboratory processes and quality of results reported; 
14.  The immediate recall of medical mariju ana or medical 
marijuana products that test above allowable threshold s or are 
otherwise determined to be unsa fe; 
15. The establishment by the laboratory of a system to document 
the complete chain of custody for samples from receipt through 
disposal; 
16. The establishment by the laboratory of a system to retain 
and maintain all required records , including business records, and   
 
Req. No. 9910 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
processes to ensure results are reported in a timely and accurate 
manner; and 
17. Any other aspect of laboratory testing of medica l marijuana 
or medical marijuana product deemed necessary by the Depa rtment. 
O.  A medical marijuana test ing laboratory shall promptly 
provide the Department or designee of the Department access to a 
report of a test and any underlying data that is conduct ed on a 
sample at the request of a medical marijuana business or qual ified 
patient.  A medical marijuana testing laboratory shall also provide 
access to the Department or designee of the Department to laboratory 
premises and to any material or information requested by the 
Department to determine compliance with the requirem ents of this 
section. 
P.  A medical marijuana testing laboratory shall retain all 
results of laboratory tests conducted on marijuana or products for a 
period of at least seven (7) years and shall make them available to 
the Department upon request. 
Q.  A medical marijuana testing laboratory shall test samples 
from each harvest batch or product batch, as appropriate, of medical 
marijuana, medical marijuana concentrate and medical marijuana 
product for each of the following categories of testing, consistent 
with standards developed by the Comm issioner: 
1.  Microbials; 
2.  Mycotoxins;   
 
Req. No. 9910 	Page 9  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  Residual solvents; 
4.  Pesticides; 
5.  Tetrahydrocannabinol (THC) and other cannabinoid potency; 
6.  Terpenoid type and concentration ; and 
7.  Heavy metals. 
R.  A licensed medical marijuana testing laboratory shall test 
each individual harvest batch .  A grower shall separate each harvest 
lot of usable marijuana into harvest batches containing no more tha n 
fifteen (15) pounds, with the exception of any plant material to be 
sold to a licensed processor for the purposes of turning the plant 
material into concentrate which may be separated into harvest 
batches of no more than fifty (50) pounds .  A processor shall 
separate each medical marijuana production lot into production 
batches containing no more tha n four (4) liters of concentrate or 
nine (9) pounds for nonliquid products, and for final products, the 
Oklahoma Medical Marijuana Authority shall be authorized to 
promulgate rules on final products as necessary .  Provided, however, 
the Authority shall not req uire testing of final products less often 
than every one thousand (1,000) grams of THC.  As used in this 
subsection, "final products" shall include, but not be l imited to, 
cookies, brownies, candies, gummies, beverages and chocola tes. 
S.  Medical marijuana testing laboratory licensure shall be 
contingent upon successful on -site inspection, successful   
 
Req. No. 9910 	Page 10  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
participation in proficiency testing and ongoing compliance with the 
applicable requirements in this section. 
T.  A medical marijuana testing laboratory shal l be inspected 
prior to initial licensure an d up to two (2) times per year 
thereafter by an inspector approved by the Authority .  The Authority 
may enter the licensed premises of a testing laboratory to conduct 
investigations and ad ditional inspections whe n the Authority 
believes an investigation or additional inspection is necessary due 
to a possible violation of applicable laws, rules or regulations. 
U.  Medical marijuana testing laboratories shall obtain 
accreditation by an accrediting body approved by the Commissioner 
within one (1) year of the date the initial license is issued .  
Renewal of any medical marijuana testing laboratory license shall be 
contingent upon accreditation in accordance with this subsection .  
All medical marijuana testing laborator ies shall obtain 
accreditation prior to applying for and receiving a medical 
marijuana testing laboratory license . 
V.  Unless authorized by the provisions of this s ection, a 
commercial grower shall not transfer or sell medical mariju ana and a 
processor shall not transfer, se ll or process into a concentrate or 
product any medical marijuana, medical marijuana concentrate or 
medical marijuana product unless samples from each harvest batch or 
production batch from which that medical marij uana, medical 
marijuana concentrate or med ical marijuana product was derived has   
 
Req. No. 9910 	Page 11  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
been tested by a medical marijuana testin g laboratory and passed all 
contaminant tests required b y the Oklahoma Medical Marijuana and 
Patient Protection Act and applicable law s, rules and regulatio ns.  
A licensed commercial grower may transfer medical marijuana that has 
failed testing to a licensed processor only for the purposes of 
decontamination or remediat ion and only in accordance with the 
provisions of the Oklahoma Medica l Marijuana and Patien t Protection 
Act and the rules and regulations of the Department .  Remediated and 
decontaminated medical marijuana may be returned only to the 
originating licensed c ommercial grower. 
W. Beginning November 1, 2022, a licensed medical marijuana 
commercial grower shall submit annually to the Authority the 
business name, business address, and business license identification 
number of every licensed medical marijuana testing laboratory that 
the commercial grower contracts with to conduct contamination tests 
on samples of its harvest batches. Licensed medical marijuana 
commercial growers shall be required to notify the Authority within 
ten (10) days of utilizing the services of a different licensed 
medical marijuana testing laboratory. 
X. Kief shall not be transferred or sold except as authorized 
in the rules and regulations o f the Department. 
SECTION 2.  This act shall become effective November 1, 2022. 
 
58-2-9910 GRS 01/04/22